Febuxostat Shows Renoprotective Effects in Gout Patients: Study
Researchers in a recent study have found that febuxostat, a medication commonly used for gout management, is associated with a decreased risk of kidney events and a slower decline in estimated glomerular filtration rate (eGFR) in patients with gout. This …